127 related articles for article (PubMed ID: 25277046)
1. Targeted mass spectrometry analysis of the proteins IGF1, IGF2, IBP2, IBP3 and A2GL by blood protein precipitation.
Such-Sanmartín G; Bache N; Callesen AK; Rogowska-Wrzesinska A; Jensen ON
J Proteomics; 2015 Jan; 113():29-37. PubMed ID: 25277046
[TBL] [Abstract][Full Text] [Related]
2. Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics.
Yoneyama T; Ohtsuki S; Honda K; Kobayashi M; Iwasaki M; Uchida Y; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Huang W; Yamada T; Tachikawa M; Terasaki T
PLoS One; 2016; 11(8):e0161009. PubMed ID: 27579675
[TBL] [Abstract][Full Text] [Related]
3. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.
Biong M; Gram IT; Brill I; Johansen F; Solvang HK; Alnaes GI; Fagerheim T; Bremnes Y; Chanock SJ; Burdett L; Yeager M; Ursin G; Kristensen VN
BMC Med Genomics; 2010 Mar; 3():9. PubMed ID: 20302654
[TBL] [Abstract][Full Text] [Related]
4. Circulating IGF system and treatment outcome in epithelial ovarian cancer.
Huang YF; Cheng WF; Wu YP; Cheng YM; Hsu KF; Chou CY
Endocr Relat Cancer; 2014 Apr; 21(2):217-29. PubMed ID: 24273235
[TBL] [Abstract][Full Text] [Related]
5. Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinoma.
Patel D; Ellis R; Howard B; Boufraqech M; Gara SK; Zhang L; Quezado MM; Nilubol N; Kebebew E
Ann Surg Oncol; 2014 Oct; 21(11):3541-7. PubMed ID: 24833102
[TBL] [Abstract][Full Text] [Related]
6. Elevated free IGF2 levels in localized, early-stage breast cancer in women.
Espelund U; Cold S; Frystyk J; Ørskov H; Flyvbjerg A
Eur J Endocrinol; 2008 Nov; 159(5):595-601. PubMed ID: 18719053
[TBL] [Abstract][Full Text] [Related]
7. An antibody-free LC-MS/MS method for the quantification of intact insulin-like growth factors 1 and 2 in human plasma.
Pratt MS; van Faassen M; Remmelts N; Bischoff R; Kema IP
Anal Bioanal Chem; 2021 Mar; 413(8):2035-2044. PubMed ID: 33569646
[TBL] [Abstract][Full Text] [Related]
8. Age-dependency of insulin-like growth factors, insulin-like growth factor-binding proteins, and acid labile subunit in plasma and wounds of surgical patients.
Wicke C; Wagner S; Trabold O; Müller J; Hunt TK; Ranke MB; Becker HD; Elmlinger MW
Wound Repair Regen; 2002; 10(6):360-5. PubMed ID: 12453139
[TBL] [Abstract][Full Text] [Related]
9. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.
Kalledsøe L; Dragsted LO; Hansen L; Kyrø C; Grønbæk H; Tjønneland A; Olsen A
Growth Horm IGF Res; 2019 Feb; 44():33-42. PubMed ID: 30622040
[TBL] [Abstract][Full Text] [Related]
10. A large, consistent plasma proteomics data set from prospectively collected breast cancer patient and healthy volunteer samples.
Riley CP; Zhang X; Nakshatri H; Schneider B; Regnier FE; Adamec J; Buck C
J Transl Med; 2011 May; 9():80. PubMed ID: 21619653
[TBL] [Abstract][Full Text] [Related]
11. Integrated solid-phase extraction-capillary liquid chromatography (speLC) interfaced to ESI-MS/MS for fast characterization and quantification of protein and proteomes.
Falkenby LG; Such-Sanmartín G; Larsen MR; Vorm O; Bache N; Jensen ON
J Proteome Res; 2014 Dec; 13(12):6169-75. PubMed ID: 25277625
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
Frystyk J; Skjaerbaek C; Vestbo E; Fisker S; Orskov H
Diabetes Metab Res Rev; 1999; 15(5):314-22. PubMed ID: 10585616
[TBL] [Abstract][Full Text] [Related]
13. Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients.
Matuschek C; Rudoy M; Peiper M; Gerber PA; Hoff NP; Buhren BA; Flehmig B; Budach W; Knoefel WT; Bojar H; Prisack HB; Steinbach G; Shukla V; Schwarz A; Kammers K; Erhardt A; Scherer A; Bölke E; Schauer M
Eur J Med Res; 2011 Oct; 16(10):451-6. PubMed ID: 22024424
[TBL] [Abstract][Full Text] [Related]
14. The development of composite circulating biomarker models for use in anticancer drug clinical development.
Lancashire LJ; Roberts DL; Dive C; Renehan AG
Int J Cancer; 2011 Apr; 128(8):1843-51. PubMed ID: 20549702
[TBL] [Abstract][Full Text] [Related]
15. Quantitative and Selective Analysis of Feline Growth Related Proteins Using Parallel Reaction Monitoring High Resolution Mass Spectrometry.
Sundberg M; Strage EM; Bergquist J; Holst BS; Ramström M
PLoS One; 2016; 11(12):e0167138. PubMed ID: 27907059
[TBL] [Abstract][Full Text] [Related]
16. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H
Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783
[TBL] [Abstract][Full Text] [Related]
17. Insulin-Like Growth Factors (IGF) and IGF-Binding Proteins (IGFBP) in the Serum of Patients with Ovarian Tumors.
Gershtein ES; Isaeva ER; Kushlinsky DN; Korotkova EA; Ermilova VD; Laktionov KP; Adamyan LV
Bull Exp Biol Med; 2016 Apr; 160(6):814-6. PubMed ID: 27165066
[TBL] [Abstract][Full Text] [Related]
18. Comparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma Con A-bound glycoprotein biomarkers in gastric cancer.
Uen YH; Lin KY; Sun DP; Liao CC; Hsieh MS; Huang YK; Chen YW; Huang PH; Chen WJ; Tai CC; Lee KW; Chen YC; Lin CY
J Proteomics; 2013 May; 83():197-213. PubMed ID: 23541716
[TBL] [Abstract][Full Text] [Related]
19. Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia.
Holt RI; Teale JD; Jones JS; Quin JD; McGregor AM; Miell JP
Growth Horm IGF Res; 1998 Dec; 8(6):447-54. PubMed ID: 10985756
[TBL] [Abstract][Full Text] [Related]
20. Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1.
Niederkofler EE; Phillips DA; Krastins B; Kulasingam V; Kiernan UA; Tubbs KA; Peterman SM; Prakash A; Diamandis EP; Lopez MF; Nedelkov D
PLoS One; 2013; 8(11):e81125. PubMed ID: 24278387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
